Table 3: Recommended treatment in the literature.
Drugs |
Mode of action |
Recommended dosing |
Precaution |
Side effects |
IFN-α |
Broad spectrum antiviral Inhibit viral RNA synthesis, viral replication and spread |
Nebulised (mild cases) 100,000-200,000 IU/kg, (severe cases) 200,000-4000,000 IU/kg or 2-4 µg/kg (in 2 mL sterile water) BD-TDS for 5-7 days
|
Liver & renal dysfunction, mental illness (suicidal ideation more common in adolescents vs adults), severe or unstable heart disease or aplastic anaemia Used with caution in < 2-months-old |
Low grade fever, flu-like symptoms, growth suppression (when used with ribavirin) Overdose: Myelosuppression, liver dysfunction, renal failure, coagulopathy |
Lopinavir/ritonavir |
Lopinavir is a substrate of CYP3A enzyme; ritonavir is a strong inhibitor of CYP3A enzyme |
Oral ≤ 15 kg: 12 mg/3 mg/kg per dose 15-40 kg: 10 mg/2.5 mg/kg per dose ≥ 40 kg: 400 mg/100 mg per dose BD for 1-2 weeks |
Liver dysfunction, jaundice, increase PR interval, heart blocks and hypokalemia Contains 42% ethanol and 15% propylene glycol, which is not recommended in < 14-days-old |
Diarrhea, vomiting, rash |
Ribavirin |
Broad spectrum antiviral with inhibitory effects on RNA & DNA viruses |
Intravenous: 10-15 mg/kg per dose (maximum of 500mg per dose) divided into BD-TDS dosing |
Liver & renal dysfunction, cardiac disease Not recommended < 3-years-old orally
|
Fever, headache, neutropenia, fatigue Overdose: Haemolytic anaemia, myocardial injury |
Chloroquine Dipohsphate |
Anti-malarial |
No recommendation |
Liver & renal dysfunction, haematoprophyria, mental illness. Use with caution in children |
Dizziness, headache, loss of appetite, ocular toxicity, arrhythmia, psychosis, leukopenia Overdose: Fatal with a dose of 50 mg/kg |
Arbidol |
|
No recommendation |
Liver dysfunction Use with caution in children |
Nausea, dizziness, diarrhea, elevated aminotransferase |